Home / Health / Future of Medicine / Sarepta’s gene therapy for Duchenne raises hopes
Genetic Editing Stock Photo

Sarepta’s gene therapy for Duchenne raises hopes

An experimental gene therapy for Duchenne muscular dystrophy, licensed to Sarepta Therapeutics, produced jaw-dropping increases in a crucial muscle protein normally missing in patients with the disease, according to preliminary clinical trial data released Tuesday.

Boston Globe’s Stat

About Boston Globe

Boston Globe

Check Also

Genetic Editing Stock Photo

Study: Damage to Genes From CRISPR Editing More Than Thought

Editing genes with CRISPR could cause significantly greater genetic havoc than experts thought, a new …

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.